Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.
Hazra R, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty JF, Yale K, Poblenz M, Kearney BP, Zhong L, Coakley DF, Blanche S, Bresson JL, Zuckerman JA, Zeichner SL. Hazra R, et al. Antimicrob Agents Chemother. 2004 Jan;48(1):124-9. doi: 10.1128/AAC.48.1.124-129.2004. Antimicrob Agents Chemother. 2004. PMID: 14693529 Free PMC article. Clinical Trial.
Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.
Markowitz M, Zolopa A, Squires K, Ruane P, Coakley D, Kearney B, Zhong L, Wulfsohn M, Miller MD, Lee WA. Markowitz M, et al. Among authors: coakley d. J Antimicrob Chemother. 2014 May;69(5):1362-9. doi: 10.1093/jac/dkt532. Epub 2014 Feb 6. J Antimicrob Chemother. 2014. PMID: 24508897 Clinical Trial.
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.
Barditch-Crovo P, Deeks SG, Collier A, Safrin S, Coakley DF, Miller M, Kearney BP, Coleman RL, Lamy PD, Kahn JO, McGowan I, Lietman PS. Barditch-Crovo P, et al. Among authors: coakley df. Antimicrob Agents Chemother. 2001 Oct;45(10):2733-9. doi: 10.1128/AAC.45.10.2733-2739.2001. Antimicrob Agents Chemother. 2001. PMID: 11557462 Free PMC article. Clinical Trial.
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
Squires K, Pozniak AL, Pierone G Jr, Steinhart CR, Berger D, Bellos NC, Becker SL, Wulfsohn M, Miller MD, Toole JJ, Coakley DF, Cheng A; Study 907 Team. Squires K, et al. Among authors: coakley df. Ann Intern Med. 2003 Sep 2;139(5 Pt 1):313-20. doi: 10.7326/0003-4819-139-5_part_1-200309020-00006. Ann Intern Med. 2003. PMID: 12965939 Clinical Trial.
Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. The Pediatrics AIDS Clinical Trials Group.
Hughes WT, Shenep JL, Rodman JH, Fridland A, Willoughby R, Blanchard S, Purdue L, Coakley DF, Cundy KC, Culnane M, Zimmer B, Burchett S, Read JS. Hughes WT, et al. Among authors: coakley df. Antimicrob Agents Chemother. 2000 Apr;44(4):1041-6. doi: 10.1128/AAC.44.4.1041-1046.2000. Antimicrob Agents Chemother. 2000. PMID: 10722509 Free PMC article. Clinical Trial.
198 results